These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 18378533)

  • 1. Professional challenges in cancer genetic testing: who is the patient?
    Chan-Smutko G; Patel D; Shannon KM; Ryan PD
    Oncologist; 2008 Mar; 13(3):232-8. PubMed ID: 18378533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM; Pei N; Taylor KM
    CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mother still knows best: cancer-related gene mutations, familial privacy, and a physician's duty to warn.
    Brownrigg A
    Fordham Urban Law J; 1999 Jan; 26(2):247-79. PubMed ID: 16437785
    [No Abstract]   [Full Text] [Related]  

  • 9. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in communication of genetic risk for hereditary breast cancer.
    Mackenzie A; Patrick-Miller L; Bradbury AR
    Breast J; 2009; 15 Suppl 1():S25-32. PubMed ID: 19775327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
    Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
    Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
    Prucka SK; McIlvried DE; Korf BR
    Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations between the patient's genotype and the course of the disease in hereditary cancer diseases].
    Bisgaard ML
    Ugeskr Laeger; 2006 Jun; 168(24):2341-4. PubMed ID: 16822416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer genetics in primary care.
    Culler D; Grimes SJ; Acheson LS; Wiesner GL
    Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic testing for cancer susceptibility: the present situation in Japan].
    Miki Y
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):930-7. PubMed ID: 9212800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based screening for colorectal cancer: The Australian perspective.
    Leggett BA
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic torts: the law of the future -- the duty of physicians to disclose the presence of a genetic disease to the relatives of their patients with the disease.
    Deftos LJ
    Univ San Francisco Law Rev; 1997; 32(1):105-37. PubMed ID: 11660530
    [No Abstract]   [Full Text] [Related]  

  • 20. Camping trips and family trees: must Tennessee physicians warn their patients' relatives of genetic risks?
    Parker CM
    Tenn Law Rev; 1998; 65(2):585-618. PubMed ID: 11863017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.